.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Fuji
Mallinckrodt
Chubb
Johnson and Johnson
Colorcon
Accenture
Cipla
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

Palbociclib - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for palbociclib and what is the scope of palbociclib patent protection?

Palbociclib
is the generic ingredient in one branded drug marketed by Pfizer Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Palbociclib has sixty-four patent family members in forty-six countries.

Two suppliers are listed for this compound.

Summary for Generic Name: palbociclib

Tradenames:1
Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list63
Clinical Trials: see list105
Patent Applications: see list96
Drug Prices:see low prices
DailyMed Link:palbociclib at DailyMed

Pharmacology for Ingredient: palbociclib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
IBRANCE
palbociclib
CAPSULE;ORAL207103-003Feb 3, 2015RXYesYes7,456,168► Subscribe ► Subscribe
Pfizer Inc
IBRANCE
palbociclib
CAPSULE;ORAL207103-001Feb 3, 2015RXYesNo► Subscribe► Subscribe
Pfizer Inc
IBRANCE
palbociclib
CAPSULE;ORAL207103-003Feb 3, 2015RXYesYes► Subscribe► Subscribe
Pfizer Inc
IBRANCE
palbociclib
CAPSULE;ORAL207103-001Feb 3, 2015RXYesNo7,208,489► SubscribeYY ► Subscribe
Pfizer Inc
IBRANCE
palbociclib
CAPSULE;ORAL207103-002Feb 3, 2015RXYesNo6,936,612► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: palbociclib

Country Document Number Estimated Expiration
HungaryS1700019► Subscribe
Australia2003237009► Subscribe
Hong Kong1104296► Subscribe
Serbia59804► Subscribe
South Korea20040077759► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PALBOCICLIB

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0863Netherlands► SubscribePRODUCT NAME: PALBOCICLIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, ESTER, AMIDE OF PROMEDICIJN DAARVAN; REGISTRATION NO/DATE: EU/1/16/1147 20161111
2017013Lithuania► SubscribePRODUCT NAME: PALBOCIKLIBAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS, ESTERIO, AMIDO ARBA PROVAISTO PAVIDALU; REGISTRATION NO/DATE: EU/1/16/1147 20161109
2017000014Germany► SubscribePRODUCT NAME: PALBOCICLIB, OPTIONAL IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, ESTERS, AMIDES ODER EINES PRODRUGS HIERVON; REGISTRATION NO/DATE: EU/1/16/1147 20161109
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
QuintilesIMS
Accenture
Baxter
Healthtrust
Teva
Covington
Mallinckrodt
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot